Pharma Company Selected to Conduct Phase 1 Trial of Inhaled Marijuana
Predicine Celebrates Grand Opening of Its R&D Facilities in Shanghai, China
Study: Diabetes Drug Development is Riskier Compared to All Drug Development
Nutra Pharma & Omnia’s Manufacturing Alliance to Produce Pediatric MS Treatment
Report: Specialized Patient Recruitment Firms Bring More Value to a Trial Than Adding Sites
A new report from Industry Standard Research (ISR), Best Practices in Patient Recruitment, shows that sponsors and CROs agree, hiring a specialized patient recruitment firm is a better value than adding more sites to the study. This is, in part, due to specialized recruitment firms having their own database of patients, a highly important attribute in recruiting for…
New OTC Topical Drug for Skin Irritations
Vanc Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter (OTC) markets, announces that Health Canada has approved Cortivera-H, a premium topical product for minor skin irritations. Cortivera-H has been approved for pharma care reimbursement program in the BC formulary and is in the process to get listed in other provincial…
German Supreme Court Upholds Invivoscribe’s FLT3 Patent Position
In a landmark patent decision that will accelerate approval of new drugs and improve treatment of patients with acute myeloid leukemia (AML), the highest court in Germany has upheld Invivoscribe Technologies Inc.’s FLT3 patent position. The decision of the German Federal Court of Justice (Bundesgerichtshof) rejected claims that the patent was invalid for lack of novelty and…
